These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Measurement of responsiveness to inhaled histamine: comparison of FEV1 and SGaw.
    Author: Cockcroft DW, Berscheid BA.
    Journal: Ann Allergy; 1983 Sep; 51(3):374-7. PubMed ID: 6614600.
    Abstract:
    The histamine provocation concentration producing a 20% reduction in FEV1 (PC20-FEV1) and that producing a 35% reduction in SGaw (PC35-SGaw) were determined on two different days in 16 asthmatics and 27 normal subjects. The PC20-FEV1 showed good separation between asthmatics and normals. All asthmatics had PC20 less than 8 mg/ml and only one normal had a PC20 slightly below 8 mg/ml. Separation was not quite as good for PC35-SGaw. All asthmatics had a PC35 less than or equal to 3 mg/ml, but four (15%) normals also had a PC35 less than 3 mg/ml. Comparison of individual points revealed that the PC35-SGaw was consistently approximately four-fold lower than the PC20-FEV1 in normals, mildly hyperreactive asthmatics and moderately hyperreactive asthmatics, but was greater than or equal to PC20-FEV1 in markedly hyperreactive asthmatics. This is consistent with inspiration-induced inhibition of bronchoconstriction during PC20-FEV1 testing in the former groups and inspiration-induced enhancement of bronchoconstriction in the latter group. We conclude that the FEV1 is clinically acceptable to measure the response to a bronchoconstricting agent and that FEV may be preferable to SGaw because of better separation of asthmatics from other groups.
    [Abstract] [Full Text] [Related] [New Search]